Gupta Gaurav, Glueck Reinhard, Rishi Narayan
Department of Virology & Biotechnology, Vaccine Technology Centre, Zydus Biologics Compound, Sarkhej Bavla NH No 8 A, Changodar, Ahmedabad, 382213, Gujarat, India; Amity Institute of Virology and Immunology, Amity University, Noida, 201303, Uttar Pradesh, India.
Department of Virology & Biotechnology, Vaccine Technology Centre, Zydus Biologics Compound, Sarkhej Bavla NH No 8 A, Changodar, Ahmedabad, 382213, Gujarat, India.
Biologicals. 2017 Mar;46:11-22. doi: 10.1016/j.biologicals.2016.12.002. Epub 2016 Dec 21.
There continues to be an urgent need for cost-effective prophylaxis for HPV-associated cancers in socio-economically underdeveloped nations. Presently HPV vaccines, which are commercially available, are adjuvanted virus-like particles (VLPs) expressed from various recombinant expression systems. They have been characterized by different methods as safe, pure, and potent HPV vaccine antigens. We cloned and expressed L1 proteins of HPV16 & 18 in Pichia pastoris and tested their immunogenicity. We observed that HPVL1 proteins (16L1 and 18L1) are expressed in Pichia pastoris at high levels. Critical physicochemical parameters of these HPV recombinant L1 proteins were characterized by SDS PAGE, western blotting, peptide mapping, glycosylation pattern, mass spectrometry, host cell DNA and protein analysis, electron microscopy, and immunogenicity analysis. These data establish a blueprint of HPV recombinant protein antigens for standardizing & developing an alternative high-quality, cost-effective vaccine for HPV as well as similar recombinant protein-based vaccines.
在社会经济欠发达国家,对人乳头瘤病毒(HPV)相关癌症进行经济高效的预防措施仍存在迫切需求。目前市面上可买到的HPV疫苗是由各种重组表达系统表达的佐剂病毒样颗粒(VLP)。它们已通过不同方法被鉴定为安全、纯净且有效的HPV疫苗抗原。我们在毕赤酵母中克隆并表达了HPV16和18的L1蛋白,并测试了它们的免疫原性。我们观察到HPV L1蛋白(16L1和18L1)在毕赤酵母中高水平表达。通过SDS-PAGE、蛋白质印迹、肽图谱分析、糖基化模式、质谱分析、宿主细胞DNA和蛋白质分析、电子显微镜以及免疫原性分析等方法对这些HPV重组L1蛋白的关键物理化学参数进行了表征。这些数据为标准化和开发一种替代的高质量、经济高效的HPV疫苗以及类似的基于重组蛋白的疫苗建立了HPV重组蛋白抗原的蓝图。